Court: Medi-Cal cuts can proceed
A federal appeals court here affirmed California’s right to cut reimbursement payments to Medi-Cal providers by 10%.
Latest
Navarro opens 32nd drug store
Navarro Discount Pharmacy has opened its 32nd store, located in Miami’s Kendall section. “The new store in West Kendall is well positioned in the Kendale Lakes Plaza among other discount brand retailers,” said president and chief executive officer Juan Ortiz.
Jensen is new CFO at Bartell
Bartell Drugs has announced the selection of Rob Jensen as chief financial officer. The community pharmacy operator noted that Jensen previously was senior vice president and CFO at Car Toys, a Seattle-based retailer of mobile entertainment, performance accessories and wireless phones.
NACDS promotes finance executive
The National Association of Chain Drug Stores has promoted David Fitzsimmons to senior vice president of finance and administration.
Medicine Chest buy brings CVS more Texas locations
CVS/pharmacy has acquired 19 of Medicine Chest’s 29 drug stores in Texas. Executives say the company will keep nine of the stores open and absorb the others into nearby existing CVS locations. Plans call for Medicine Chest to continue to operate its remaining 10 stores.
Senator goes to bat for more MTM coverage
North Carolina Sen. Kay Hagan continues to be hailed by community pharmacy advocates for her efforts to improve patient care. The National Association of Chain Drug Stores, for instance, recently cited the Democratic lawmaker for her continued leadership on behalf of pharmacy patient care.
Health reform hits snags with exchanges, Medicaid
Half the states in the country have refused to create the health insurance exchanges called for under the health care reform law, according to data compiled by the Henry J. Kaiser Family Foundation.
Rite Aid to use Surescripts network to deliver e-records
Rite Aid Corp. will leverage the Surescripts Network for Clinical Interoperability to electronically deliver patient immunization notifications directly to health care providers.
AmerisourceBergen names global sourcing chief
AmerisourceBergen Corp. has named Peyton Howell as a corporate senior vice president and as president of global sourcing and manufacturer relations.
The overarching concern for retail pharmacy
As the new year begins, retail pharmacy operators are confronted with a host of pressing issues that will affect the measure of success they can achieve as health care providers and business enterprises.
PhRMA: What’s ahead for biopharmaceuticals in 2013?
It’s human nature to look ahead to the New Year. What will 2013 hold for America’s biopharmaceutical research sector? Well, quite a bit. John Castellani We will join other stakeholders in the dialogue over the role of health care costs in our nation’s economic challenges.
CACDS names Carpenter as CEO
Denise Carpenter has joined the Canadian Association of Chain Drug Stores (CACDS) as president and chief executive officer.
Wasson, Pessina are <i>CDR’s</i> Retailers of the Year
Striking a blockbuster deal that could shift the industry’s perspective, Walgreen Co. chief executive officer Greg Wasson and Alliance Boots executive chairman Stefano Pessina — and their management teams — have been selected as the 2012 Retailers of the Year by Chain Drug Review.
Avanti rolls out new greeting cards for new year
Avanti Press Inc. has unveiled its greeting card collection for 2013 and hired a new director of business development.
Frito-Lay brings back ‘Doritos Girl’ for Super Bowl ad contest
"Doritos Girl" Ali Landry, who rose to fame 15 years ago by starring in a Doritos Super Bowl ad, has reunited with the snack chip brand in announcing the five finalists for this year’s "Doritos Crash the Super Bowl" contest.
Watson cleared to release Lysteda generic
Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for tranexamic acid tablets, a medication for menstrual bleeding. The company said Thursday that it will immediately begin shipping the product, which is a generic equivalent to Ferring Pharmaceuticals’ Lysteda.